Every SEC Form 3/4/5 on record for this filer (CIK 1305361) — 8 issuers, 53 transactions. Section-16 filings only: what they filed, not a biography, and titles are as filed on their latest form at each issuer.
| Ticker | Company | Role as filed | On file | Forms | Open-market net |
|---|---|---|---|---|---|
| NPO | Enpro Inc. | Director | 2021-09-01 → 2026-06-18 | 22 | — |
| NRIX | Nurix Therapeutics, Inc. | Director | 2021-10-01 → 2026-05-15 | 7 | — |
| TOL | Toll Brothers, Inc. | Director | 2023-12-19 → 2026-01-20 | 4 | — |
| CNR | Core Natural Resources, Inc. | Director · lapsed | 2021-08-20 → 2022-07-26 | 3 | — |
| ALXN | ALEXION PHARMACEUTICALS, INC. | Director · lapsed | 2018-02-08 → 2021-07-23 | 8 | — |
| DNB | DUN & BRADSTREET CORP/NW | Director · lapsed | 2015-09-15 → 2019-02-12 | 17 | — |
| JCI | Johnson Controls International plc | Executive VP & General Counsel · lapsed | 2016-09-07 → 2017-10-16 | 9 | — |
| TYC | TYCO INTERNATIONAL plc | EVP and General Counsel · lapsed | 2015-08-12 → 2016-01-14 | 6 | −$4M |
No open-market buy or sale on record — only grants, exercises, withholding or gifts. Switch to “All forms” to see them.
5 of 8 issuers are covered and open a security page; the rest are on file here only.
